GPCRs are important drug targets requiring receptor-protein interaction and trafficking studies to reveal how they function. Bioluminescence resonance energy transfer (BRET) is a versatile tool to study receptor biology. Its limitation of ectopic expression of labelled interaction partners is now overcome by CRISPR/Cas9 genome editing.